Instylla
Pre-clinicalDevelops liquid embolic technology for minimally invasive treatments of hypervascular tumors and vascular malformations.
Founded
2016
Focus
OncologyMedical Devices
About
Develops liquid embolic technology for minimally invasive treatments of hypervascular tumors and vascular malformations.
Funding History
2Total raised: $107M
Series B$66MF-Prime CapitalJun 15, 2023
Series A$41MF-Prime CapitalOct 15, 2021
Company Info
TypePrivate
Founded2016
LocationBedford, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile